Stock CCAP CRESCENT CAPITAL BDC, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Crescent Capital BDC, Inc.

Equities

CCAP

US2256551092

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
17.99 USD +1.01% Intraday chart for Crescent Capital BDC, Inc. +0.62% +3.51%
May. 23 Keefe, Bruyette & Woods Adjusts Price Target on Crescent Capital BDC to $19 From $18.50, Maintains Outperform Rating MT
May. 13 Wells Fargo Adjusts Price Target on Crescent Capital BDC to $18 From $16.50, Maintains Equal-Weight Rating MT

Summary

  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The equity is one of the most attractive in the market with regard to earnings multiple-based valuation.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Sales forecast by analysts have been recently revised upwards.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
  • Historically, the company has been releasing figures that are above expectations.

Weaknesses

  • According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
  • The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.

Ratings chart - Surperformance

Sector: Closed End Funds

1st Jan change Capi. Investor Rating ESG Refinitiv
CRESCENT CAPITAL BDC, INC. Stock Crescent Capital BDC, Inc.
+3.51% 667M -
ARES CAPITAL CORPORATION Stock Ares Capital Corporation
+6.59% 13.12B
C
PERSHING SQUARE HOLDINGS, LTD. Stock Pershing Square Holdings, Ltd.
+12.07% 9.57B -
C-
FS KKR CAPITAL CORP. Stock FS KKR Capital Corp.
+0.70% 5.63B
D+
SPROTT PHYSICAL URANIUM TRUST FUND Stock Sprott Physical Uranium Trust Fund
+4.64% 5.38B -
D
PIMCO DYNAMIC INCOME FUND Stock PIMCO Dynamic Income Fund
+6.91% 5.25B - -
SPROTT PHYSICAL SILVER TRUST Stock Sprott Physical Silver Trust
+25.62% 4.92B - -
SPROTT PHYSICAL GOLD AND SILVER TRUST Stock Sprott Physical Gold and Silver Trust
+20.77% 4.61B - -
MACQUARIE KOREA INFRASTRUCTURE FUND Stock Macquarie Korea Infrastructure Fund
+2.73% 4.08B -
3I INFRASTRUCTURE PLC Stock 3i Infrastructure plc
+2.80% 3.89B -
C-
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
-
Profitability
Finances
-

Valuation

P/E ratio
EV / Sales
-
Price to Book
-
Price to Free Cash Flow
-
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. CCAP Stock
  4. Ratings Crescent Capital BDC, Inc.